The cost of Omnitrope can vary significantly depending on factors such as dosage, insurance coverage, and whether it is purchased through a pharmacy or a patient assistance program. While specific price points are not publicly disclosed by the manufacturer, Sandoz, the approximate cost for a carton of Omnitrope cartridges, which contain multiple doses, can range from several hundred to over a thousand dollars.
How is Omnitrope prescribed?
Omnitrope is a biosimilar to human growth hormone and is used to treat growth failure in children and growth hormone deficiency in adults. It is administered via subcutaneous injection, with dosages determined by a healthcare professional based on the patient's specific condition and needs [1].
Can I get financial assistance for Omnitrope?
Patients may be eligible for financial assistance programs. Sandoz, the manufacturer of Omnitrope, offers programs that can help reduce out-of-pocket costs for eligible individuals. These programs often have specific income and insurance requirements [2].
What is the difference between Omnitrope and other growth hormones?
Omnitrope is a biosimilar, meaning it is highly similar to another already approved biological medicine (the reference product) and has no clinically meaningful differences in terms of safety, purity, and potency. It is specifically a biosimilar to Genotropin. Biosimilars offer a potential alternative to originator biologics, often at a different price point [3].
When does the patent for Omnitrope expire?
The patent status and expiration dates for biosimilars like Omnitrope can be complex and may vary depending on specific patents related to the drug's formulation, manufacturing process, or indications. Information on patent expiry can often be found through specialized patent databases [4].